Systematic Reviews
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 850-866
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.850
Table 1 Summary of randomized controlled trials
Ref.
Purpose
Type of study
Sample size
Conclusion
Setting
Philips et al[11]Assessed the use of 5% human fluid for the resuscitation of cirrhotic patients with sepsisThree hundred-eight patients were divided into two groups5% human albumin was safe and more beneficial in correcting hypotension than normal salineICU
Arabi et al[13] Assess the use of a low dose of hydrocortisone in cirrhotic patients with sepsisRCT140 patients were 65 excluded, and 39 received hydrocortisone and 36 placeboesThat study did not find mortality improvement with corticosteroids despite hemodynamic improvement. The treatment proposed: Hemodynamic monitoring and management, laboratory test culture, stress ulcer prophylaxis as histamine H2 receptor antagonists, norepinephrine as vasopressors, and empiric antibiotic. The outcome was 28 days of all-cause mortalityICU